Results 121 to 130 of about 14,129 (184)

Anti-gallbladder cancer activities and toxicity studies of glycyrrhetinic acid derivative as a novel PPARγ agonist. [PDF]

Front Immunol
Liu M, Ma H, Xiong G, Qi M, Xia Y, Zhao Y, Ji C, Sun J, Sun T.   +8 more
europepmc   +1 more source

The Role of Dicer Phosphorylation in Gemcitabine Resistance of Pancreatic Cancer. [PDF]

Int J Mol Sci
Chiu CF, Lin HR, Su YH, Chen HA, Hung SW, Huang SY.   +5 more
europepmc   +1 more source

Extracellular RNA as a molecular driver and therapeutic target in abdominal aortic aneurysms. [PDF]

Sci Rep
Ibrahim N, Hayden H, Kurzreiter G, Klopf J, Bleichert S, Artner T, Stiglbauer-Tscholakoff A, Eilenberg W, Neumayer C, Brostjan C.   +9 more
europepmc   +1 more source

Inter-alpha-Trypsin Inhibitor of Human Serum [PDF]

, 1983
Bittner, A., Jochum, Marianne
core  

Src Reduces Neutrophil Extracellular Traps Generation and Resolves Acute Organ Damage. [PDF]

Adv Sci (Weinh)
Lu G, Han F, Wang Y, Yuan C, Zhu Q, Xia T, Chen L, Dong X, Ding Y, Xiao W, Zhang Y, Pan J, Xu H, Chen W, Tu B, Li W, Wang F, Gong W, Hu L.   +18 more
europepmc   +1 more source

RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer. [PDF]

Signal Transduct Target Ther
Zha Z, Liu C, Yan M, Chen C, Yu C, Chen Y, Zhou C, Li L, Li YC, Yamaguchi H, Ye L, Liu T, Wang YN, Lee HH, Yang WH, Chan LC, Ke B, Hsu JL, Ding L, Ji D, Pan P, Meng Y, Pu Y, Liu L, Hung MC.   +24 more
europepmc   +1 more source

Solution NMR evidence for a cis Tyr-Ala peptide group in the structure of [Pro93Ala] bovine pancreatic ribonuclease A. [PDF]

Protein Sci, 2000
Xiong Y, Juminaga D, Swapna GV, Wedemeyer WJ, Scheraga HA, Montelione GT.   +5 more
europepmc   +1 more source

Solvation free energy in governing equations for DNA hybridization, protein-ligand binding, and protein folding. [PDF]

FEBS Open Bio
Harmon C, Bui A, Espejo JM, Gancayco M, Le JM, Rangel J, Eggers DK.   +6 more
europepmc   +1 more source

Chemical denaturation of bovine pancreatic Ribonuclease A

, 2019
openaire   +2 more sources

EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells. [PDF]

Sci Rep
Jafary B, Akbarzadeh-Khiavi M, Farzi-Khajeh H, Safary A, Adibkia K.   +4 more
europepmc   +1 more source